COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Norgine welcomes positive CHMP opinion recommending approval of mavorixafor in the European Union for WHIM syndrome
Norgine's mavorixafor receives positive CHMP opinion for WHIM syndrome treatment in the EU. Final EC decision expected in Q2 2026. Partnership with X4 Pharmaceuticals -
COMMUNIQUÉ DE PRESSE
Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment
Sanofi and Regeneron's Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment. Positive CHMP opinion based on clinical studies -
COMMUNIQUÉ DE PRESSE
Communiqué de presse : Dupixent de Sanofi et Regeneron recommandé pour approbation dans l'UE dans le traitement de l'urticaire chronique spontanée chez les jeunes enfants dont les symptômes persistent malgré un traitement
Le Dupixent de Sanofi et Regeneron est recommandé pour l'approbation dans l'UE pour traiter l'urticaire chronique spontanée chez les jeunes enfants. Décision finale à venir -
COMMUNIQUÉ DE PRESSE
Nextech3D.ai Launches Eventdex AI Voice Concierge, Powered by OpenClaw, Twilio, AWS EC2 & Pinecone - Expanding Its AI Events Operating System
Nextech3D.ai launches Eventdex AI Voice Concierge, a production-ready AI voice automation layer for enterprise events. Uses modern technology stack for low-latency responses and human escalation. New monetization opportunities for high-margin ROI -
-
-
-
-
